Literature DB >> 15341892

Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey.

Luca Vignatelli1, Roberto D'Alessandro, Paola Mosconi, Luigi Ferini-Strambi, Loredana Guidolin, Armando De Vincentiis, Giuseppe Plazzi.   

Abstract

OBJECTIVE: To evaluate the psychometric performances of the 36-item short form (SF-36), a tool measuring health-related quality of life (HRQoL) in patients with narcolepsy or other sleep disorders, presenting excessive daytime sleepiness (EDS) as the main symptom. To compare the HRQoL of patients with narcolepsy with the Italian norm. To disclose the clinical predictors influencing the HRQoL. PATIENTS AND METHODS: One hundred and eight adults with narcolepsy, 115 with obstructive sleep apnea syndrome (OSAS) and 42 with idiopathic hypersomnia (IH) enrolled for a multicentric cross-section study employing self-administered questionnaires investigating the HRQoL (SF-36), EDS and cataplexy. A psychometric analysis and the standardized scoring of the 8 scales of the SF-36 were performed. The correlation between SF-36 scales and clinical features of narcolepsy was measured by a multiple linear regression analysis.
RESULTS: SF-36 satisfied the recommended psychometric standards. Patients with narcolepsy had all domains except Bodily Pain lower than the Italian norm. Some of the variance of Physical Functioning (R(2) 0.07), Role functioning-Physical (R(2) 0.31), General Health (R(2) 0.15), Vitality (R(2) 0.10), Social Functioning (R(2) 0.21) and Role functioning-Emotional (R(2) 0.15) was explained both by EDS (inverse correlation) and disease duration (direct correlation).
CONCLUSIONS: The SF-36 form is a reliable outcome measure for hypersomniac disorders. Narcolepsy seriously impacts patients' HRQoL in terms of physical and mental well-being and impairs physical and emotional functions, restricting social life. EDS is the main symptom determining this impairment. However, disease duration plays a role in counterbalancing this feature, probably by means of adaptation.

Entities:  

Mesh:

Year:  2004        PMID: 15341892     DOI: 10.1016/j.sleep.2004.04.003

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  23 in total

Review 1.  Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management.

Authors:  Michael J Thorpy
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Functional impairment in adult sleepwalkers: a case-control study.

Authors:  Regis Lopez; Isabelle Jaussent; Sabine Scholz; Sophie Bayard; Jacques Montplaisir; Yves Dauvilliers
Journal:  Sleep       Date:  2013-03-01       Impact factor: 5.849

3.  The economic consequences of narcolepsy.

Authors:  Poul Jennum; Stine Knudsen; Jakob Kjellberg
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

4.  Psychosocial Characteristics of Children with Central Disorders of Hypersomnolence Versus Matched Healthy Children.

Authors:  Kristin T Avis; Jiabin Shen; Patrick Weaver; David C Schwebel
Journal:  J Clin Sleep Med       Date:  2015-11-15       Impact factor: 4.062

5.  Body mass index-independent metabolic alterations in narcolepsy with cataplexy.

Authors:  Francesca Poli; Giuseppe Plazzi; Guido Di Dalmazi; Danilo Ribichini; Valentina Vicennati; Fabio Pizza; Emmanuel Mignot; Pasquale Montagna; Renato Pasquali; Uberto Pagotto
Journal:  Sleep       Date:  2009-11       Impact factor: 5.849

6.  High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy.

Authors:  Francesca Poli; Fabio Pizza; Emmanuel Mignot; Raffaele Ferri; Uberto Pagotto; Shahrad Taheri; Elena Finotti; Filippo Bernardi; Piero Pirazzoli; Alessandro Cicognani; Antonio Balsamo; Lino Nobili; Oliviero Bruni; Giuseppe Plazzi
Journal:  Sleep       Date:  2013-02-01       Impact factor: 5.849

Review 7.  Prevalence of Depression or Depressive Symptoms in Patients with Narcolepsy: a Systematic Review and Meta-Analysis.

Authors:  Xiao Li; Larry D Sanford; Qiang Zong; Ye Zhang; Lu Tan; Taomei Li; Rong Ren; Junying Zhou; Fang Han; Xiangdong Tang
Journal:  Neuropsychol Rev       Date:  2020-07-15       Impact factor: 7.444

Review 8.  Evidence-based recommendations for the assessment and management of sleep disorders in older persons.

Authors:  Harrison G Bloom; Imran Ahmed; Cathy A Alessi; Sonia Ancoli-Israel; Daniel J Buysse; Meir H Kryger; Barbara A Phillips; Michael J Thorpy; Michael V Vitiello; Phyllis C Zee
Journal:  J Am Geriatr Soc       Date:  2009-05       Impact factor: 5.562

9.  Health-related quality of life among drug-naïve patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time.

Authors:  Akiko Ozaki; Yuichi Inoue; Toru Nakajima; Kenichi Hayashida; Makoto Honda; Yoko Komada; Kiyohisa Takahashi
Journal:  J Clin Sleep Med       Date:  2008-12-15       Impact factor: 4.062

Review 10.  Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing.

Authors:  Neil T Feldman
Journal:  Sleep Breath       Date:  2009-07-23       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.